News
ACCD
7.02
0.00%
0.00
*News On Accolade Inc. (ACCD) Now Under TRNS.XX
Dow Jones · 04/08/2025 21:08
Accolade Completes Merger, Plans Nasdaq Delisting
TipRanks · 04/08/2025 14:14
Weekly Report: what happened at ACCD last week (0331-0404)?
Weekly Report · 04/07/2025 09:02
Weekly Report: what happened at ACCD last week (0324-0328)?
Weekly Report · 03/31/2025 09:02
Accolade Stockholders Approve Merger with Transcarent
TipRanks · 03/27/2025 21:27
Accolade announces stockholder approval for Transcarent merger
TipRanks · 03/27/2025 20:25
Accolade Announces That Stockholders Voted To Approve Merger With Transcarent
Benzinga · 03/27/2025 20:10
ACCOLADE STOCKHOLDERS APPROVE MERGER BETWEEN ACCOLADE AND TRANSCARENT
Reuters · 03/27/2025 20:05
Press Release: Accolade Stockholders Approve Merger Between Accolade and Transcarent
Dow Jones · 03/27/2025 20:05
Weekly Report: what happened at ACCD last week (0317-0321)?
Weekly Report · 03/24/2025 09:02
Catalyst Watch: CoreWeave IPO, Dollar Tree earnings, Newsmax pricing, and GameStop crypto intrigue
Seeking Alpha · 03/21/2025 19:00
Weekly Report: what happened at ACCD last week (0310-0314)?
Weekly Report · 03/17/2025 09:02
Do Options Traders Know Something About Accolade (ACCD) Stock We Don't?
Barchart · 03/13/2025 09:44
Weekly Report: what happened at ACCD last week (0303-0307)?
Weekly Report · 03/10/2025 09:02
U.S. RESEARCH ROUNDUP-Accolade, CrowdStrike, Marriott International
Reuters · 03/05/2025 07:53
Accolade downgraded to Neutral from Overweight at Piper Sandler
TipRanks · 03/04/2025 21:12
Weekly Report: what happened at ACCD last week (0224-0228)?
Weekly Report · 03/03/2025 09:02
Cathie Wood's Ark Invest Loads Up On Tempus AI, Archer Aviation, But Sells Twist Bioscience: Here Are Key Ark Trades This Friday
Benzinga · 03/01/2025 10:06
Accolade and Transcarent announce HSR waiting period expiration for merger
TipRanks · 02/24/2025 22:25
TRANSCARENT AND ACCOLADE ANNOUNCE EXPIRATION OF HART-SCOTT RODINO WAITING PERIOD FOR PENDING MERGER TRANSACTION
Reuters · 02/24/2025 22:20
More
Webull provides a variety of real-time ACCD stock news. You can receive the latest news about Accolade, Inc. through multiple platforms. This information may help you make smarter investment decisions.
About ACCD
Accolade, Inc. provides personalized, technology-enabled solutions that help people understand, navigate, and utilize the healthcare system and their workplace benefits. Its customers are primarily employers that deploy Accolade solutions in order to provide employees and their families with a single place to turn for their health, healthcare, and benefits needs. It also offers medical opinion services to commercial customers and virtual primary care and mental health support. Its platform, True Health Engine, combines open, cloud-based intelligent technology with multimodal support from a team of empathetic and knowledgeable Accolade Health Assistants and clinicians, including registered nurses, physician medical directors, pharmacists, behavioral health specialists, women’s health specialists, case management specialists, expert medical opinion providers, and virtual primary care physicians. Its offerings include Accolade Expert MD, Accolade Care, Plus and Connect and Accolade One.